These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19848604)

  • 1. Epidemiology and outcomes of hospitalizations with complicated skin and skin-structure infections: implications of healthcare-associated infection risk factors.
    Zilberberg MD; Shorr AF; Micek ST; Hoban AP; Pham V; Doherty JA; Ramsey AM; Kollef MH
    Infect Control Hosp Epidemiol; 2009 Dec; 30(12):1203-10. PubMed ID: 19848604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for mixed complicated skin and skin structure infections to help tailor appropriate empiric therapy.
    Zilberberg M; Micek ST; Kollef MH; Shelbaya A; Shorr AF
    Surg Infect (Larchmt); 2012 Dec; 13(6):377-82. PubMed ID: 23216526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospitalizations with healthcare-associated complicated skin and skin structure infections: impact of inappropriate empiric therapy on outcomes.
    Zilberberg MD; Shorr AF; Micek ST; Chen J; Ramsey AM; Hoban AP; Pham V; Doherty JA; Mody SH; Kollef MH
    J Hosp Med; 2010; 5(9):535-40. PubMed ID: 20734456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial management of complicated skin and skin structure infections in the era of emerging resistance.
    Lee SY; Kuti JL; Nicolau DP
    Surg Infect (Larchmt); 2005; 6(3):283-95. PubMed ID: 16201938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Between community and hospital: healthcare-associated gram-negative bacteremia among hospitalized patients.
    Marschall J; Fraser VJ; Doherty J; Warren DK
    Infect Control Hosp Epidemiol; 2009 Nov; 30(11):1050-6. PubMed ID: 19803723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healthcare-associated bloodstream infection: A distinct entity? Insights from a large U.S. database.
    Shorr AF; Tabak YP; Killian AD; Gupta V; Liu LZ; Kollef MH
    Crit Care Med; 2006 Oct; 34(10):2588-95. PubMed ID: 16915117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and safety of ceftobiprole in the treatment of complicated skin and skin structure infections: evidence from 2 clinical trials.
    Deresinski SC
    Diagn Microbiol Infect Dis; 2008 May; 61(1):103-9. PubMed ID: 18384998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study.
    Wilcox MH; Tack KJ; Bouza E; Herr DL; Ruf BR; Ijzerman MM; Croos-Dabrera RV; Kunkel MJ; Knirsch C
    Clin Infect Dis; 2009 Jan; 48(2):203-12. PubMed ID: 19072714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolated pathogens and clinical outcomes of adult bacteremia in the emergency department: a retrospective study in a tertiary Referral Center.
    Kao CH; Kuo YC; Chen CC; Chang YT; Chen YS; Wann SR; Liu YC
    J Microbiol Immunol Infect; 2011 Jun; 44(3):215-21. PubMed ID: 21524617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for acquiring potentially drug-resistant pathogens in immunocompetent patients with pneumonia developed out of hospital.
    Jeong BH; Koh WJ; Yoo H; Park HY; Suh GY; Chung MP; Kwon OJ; Jeon K
    Respiration; 2014; 88(3):190-8. PubMed ID: 24994099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inappropriate initial antibiotic treatment for complicated skin and soft tissue infections in hospitalized patients: incidence and associated factors.
    Lipsky BA; Napolitano LM; Moran GJ; Vo L; Nicholson S; Kim M
    Diagn Microbiol Infect Dis; 2014 Jun; 79(2):273-9. PubMed ID: 24661685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complicated skin and soft tissue infection.
    Dryden MS
    J Antimicrob Chemother; 2010 Nov; 65 Suppl 3():iii35-44. PubMed ID: 20876627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience.
    Micek ST; Kollef KE; Reichley RM; Roubinian N; Kollef MH
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3568-73. PubMed ID: 17682100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delays in appropriate antibiotic therapy for gram-negative bloodstream infections: a multicenter, community hospital study.
    Moehring RW; Sloane R; Chen LF; Smathers EC; Schmader KE; Fowler VG; Weber DJ; Sexton DJ; Anderson DJ
    PLoS One; 2013; 8(10):e76225. PubMed ID: 24098449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and outcome of community-acquired pneumonia due to Gram-negative bacilli.
    Falguera M; Carratalà J; Ruiz-Gonzalez A; Garcia-Vidal C; Gazquez I; Dorca J; Gudiol F; Porcel JM
    Respirology; 2009 Jan; 14(1):105-11. PubMed ID: 18699803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infection reduction strategies including antibiotic stewardship protocols in surgical and trauma intensive care units are associated with reduced resistant gram-negative healthcare-associated infections.
    Dortch MJ; Fleming SB; Kauffmann RM; Dossett LA; Talbot TR; May AK
    Surg Infect (Larchmt); 2011 Feb; 12(1):15-25. PubMed ID: 21091186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of complicated skin and skin structure infections in areas with low incidence of antibiotic resistance-a retrospective population based study from Finland and Sweden.
    Jääskeläinen IH; Hagberg L; From J; Schyman T; Lehtola L; Järvinen A
    Clin Microbiol Infect; 2016 Apr; 22(4):383.e1-383.e10. PubMed ID: 26806138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmarketing clinical experience in patients with skin and skin-structure infections treated with daptomycin.
    Owens RC; Lamp KC; Friedrich LV; Russo R
    Am J Med; 2007 Oct; 120(10 Suppl 1):S6-12. PubMed ID: 17904950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical profile of ceftobiprole, a novel beta-lactam antibiotic.
    Noel GJ
    Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():25-9. PubMed ID: 17488373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
    Vasilev K; Reshedko G; Orasan R; Sanchez M; Teras J; Babinchak T; Dukart G; Cooper A; Dartois N; Gandjini H; Orrico R; Ellis-Grosse E;
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i29-40. PubMed ID: 18684704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.